GSC
ZBH icon

Grey Street Capital’s Zimmer Biomet ZBH Stock Holding History

Grey Street Capital’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$427K Buy
+3,226
New +$403K 0.06% 326

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Grey Street Capital's ZBH Position: Q1 2024 in Review

Grey Street Capital opened a new position in Zimmer Biomet (ZBH) in Q1 2024: 3,226 shares worth $427K. The stake represents 0.06% of the portfolio and ranks #326 among its holdings.

1,012 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.

  • Grey Street Capital held 3,226 shares of Zimmer Biomet worth $427K as of Q1 2024.
  • Zimmer Biomet was a new Grey Street Capital position in Q1 2024.
  • Zimmer Biomet made up 0.06% of Grey Street Capital's portfolio in Q1 2024, its #326 holding.
  • 1,012 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.

Based on Grey Street Capital's 13F filing for Q1 2024, filed 9 Aug 2024.